From: Brett Calabrese <bcalabrese@yahoo.com> Subject: [ibogaine] Rough ritual with datura Date: August 31, 2002 at 7:10:47 PM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com and I thought ibogaine was rough. http://leda.lycaeum.org/Documents/The_Genus_Datura:_From_Research_Subject_to_Powerful_Hallucinogen.16212.shtml snip “Beverly in his History of Virginia (1705) described the rite of huskanawing. The rite was practiced by Algonquins every fourteen…
Continue reading
From: “Ashley” <ashley1980@iamwasted.com> Subject: [ibogaine] hi! Date: May 31, 2002 at 10:56:01 PM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com Hi nobody answers any of my emails so far. Please reply! This place is so dope! Awesome awesome! But I am totally lost. Where is this? I saw the logos up at…
Continue reading
From: robertbosch@softhome.net Subject: [ibogaine] Re: ssris Date: April 30, 2002 at 5:50:18 PM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com HSLotsof@aol.com writes: In a message dated 4/25/02 10:52:09 PM, robertbosch@softhome.net writes: << Hello, I understand this is a tense time or something and do not want to be rude, but if anyone…
Continue reading
From: “preston peet” <ptpeet@nyc.rr.com> Subject: [ibogaine] news links for march 30-31, 2002 @ drugwar.com Date: March 31, 2002 at 4:16:28 PM EST To: “spynews” <spynews@yahoogroups.com> Cc: “rootsofteror” <rootsofterror@yahoogroups.com>, <ibogaine@mindvox.com>, <FreedomNewsNet@aol.com>, “CRRH” <restore@crrh.org>, “cia-drugs” <cia-drugs@yahoogroups.com> Reply-To: ibogaine@mindvox.com Greetings all, Happy Easter, joyous Passover, good Spring Solstice, and to all who practice…
Continue reading
Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…
Continue reading
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
Continue reading
by Brian Vastag Journal of the American Medical Association Vol. 288 No. 24, pp. 3096-3101, December 25, 2002 © 2002 American Medical Association. All rights reserved. Tabernanthe iboga, the West African source of ibogaine, used by some to treat addiction. New York — Some drugs are made in laboratories. Others,…
Continue reading
ADDICTION RESEARCH: Ibogaine Therapy: A ‘Vast, Uncontrolled Experiment’ by Brian Vastag (Science, Vol 308, Issue 5720, 345-346 , 15 April 2005) Despite potentially harsh side effects, an African plant extract is being tested in two public clinical trials — and many clandestine ones On a snowy President’s Day, an odd…
Continue reading
Alexander Shulgin Reproduced by permission of author. (Original Publication: TiHKAL) There have been three total syntheses of ibogaine reported in the chemical literature. The first of these was a thirteen step process published about 30 years ago. Although the chemistry lab can serve a fine function for both isolation and…
Continue reading
Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of…
Continue reading
